Skip to main content

HARVARD BIOSCIENCE INC

For the period ended Sep 30, 2026. Filed Nov 10, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 10, 2026

HBIO$9.26+1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

FORM 10-Q

INDEX

Page
PART I - FINANCIAL INFORMATION1
Item 1. Financial Statements (unaudited)1
Condensed Consolidated Balance Sheets1
Condensed Consolidated Statements of Operations2
Condensed Consolidated Statements of Comprehensive Loss3
Condensed Consolidated Statements of Stockholders' Equity4
Condensed Consolidated Statements of Cash Flows5
Notes to Condensed Unaudited Consolidated Financial Statements6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3. Quantitative and Qualitative Disclosures about Market Risk23
Item 4. Controls and Procedures23
PART II - OTHER INFORMATION23
Item 1. Legal Proceedings23
Item1A. Risk Factors23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.23
Item 3. Defaults Upon Senior Securities23
Item 4. Mine Safety Disclosures23
Item 5. Other Information23
Item 6. Exhibits24
SIGNATURES24

**PART I. FINANCIAL INFORMATION

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.